Purpose of this Study: This study examines if a new medication is safe and effective in treating patients with Bipolar disorder who are currently depressed.
Design of Study: This is an outpatient study and all participants will receive either the study medication or a placebo. Participants on Depakote or Lithium may stay on these medications throughout the study.
Length of Study: Nine (9) visits over 10 weeks.
Qualified Study Participants Will Receive:
- Study-related care and office visits at no cost
- Medication at no cost
- $75 compensation per visit
Am I Eligible for the Study?
- Aged 18 – 65 years old
- Diagnosis of Bipolar Disorder
- Current depressive episode lasting from 2 weeks to 6 months
- Medically stable with a stable living residence
Note: These are not the only eligibility criteria for this clinical research study, and other criteria may exclude you.
Why Should You Participate? Clinical trials are how all new medicines are tested. These trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. You may also help others by advancing science and may gain access to a new treatment.
Interested in Participating? If you are interested in joining this study, please fill out the form below to provide your contact information, or call our office at (773) 989-8313 x 2 and leave a message on our screening line. A member of our staff will call you back within 24 hours and will conduct a short phone screen to determine if you should visit our office for further evaluation.